Your browser doesn't support javascript.
loading
Secreted cellular prion protein binds doxorubicin and correlates with anthracycline resistance in breast cancer.
Wiegmans, Adrian P; Saunus, Jodi M; Ham, Sunyoung; Lobb, Richard; Kutasovic, Jamie R; Dalley, Andrew J; Miranda, Mariska; Atkinson, Caroline; Foliaki, Simote T; Ferguson, Kaltin; Niland, Colleen; Johnstone, Cameron N; Lewis, Victoria; Collins, Steven J; Lakhani, Sunil R; Al-Ejeh, Fares; Möller, Andreas.
Afiliação
  • Wiegmans AP; Tumor Microenvironment Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
  • Saunus JM; Centre for Clinical Research, Faculty of Medicine, The University of Queensland, Herston, Queensland, Australia.
  • Ham S; Tumor Microenvironment Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
  • Lobb R; Tumor Microenvironment Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
  • Kutasovic JR; Centre for Clinical Research, Faculty of Medicine, The University of Queensland, Herston, Queensland, Australia.
  • Dalley AJ; Centre for Clinical Research, Faculty of Medicine, The University of Queensland, Herston, Queensland, Australia.
  • Miranda M; Personalized Medicine Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
  • Atkinson C; Children's Cancer Institute Australia, Lowy Cancer Research Centre, University of New South Wales, Sydney, New South Wales, Australia.
  • Foliaki ST; Department of Medicine (Royal Melbourne Hospital), The University of Melbourne, Parkville, Victoria, Australia.
  • Ferguson K; Centre for Clinical Research, Faculty of Medicine, The University of Queensland, Herston, Queensland, Australia.
  • Niland C; Centre for Clinical Research, Faculty of Medicine, The University of Queensland, Herston, Queensland, Australia.
  • Johnstone CN; Cancer and Inflammation Laboratory, Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria, Australia.
  • Lewis V; Department of Medicine (Royal Melbourne Hospital), The University of Melbourne, Parkville, Victoria, Australia.
  • Collins SJ; Department of Medicine (Royal Melbourne Hospital), The University of Melbourne, Parkville, Victoria, Australia.
  • Lakhani SR; Centre for Clinical Research, Faculty of Medicine, The University of Queensland, Herston, Queensland, Australia.
  • Al-Ejeh F; Pathology Queensland, The Royal Brisbane and Women's Hospital, Herston, Queensland, Australia.
  • Möller A; Personalized Medicine Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
JCI Insight ; 52019 02 26.
Article em En | MEDLINE | ID: mdl-30830863
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Biomarcadores Tumorais / Resistencia a Medicamentos Antineoplásicos / Antraciclinas / Proteínas Priônicas / Antibióticos Antineoplásicos Idioma: En Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Austrália
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Biomarcadores Tumorais / Resistencia a Medicamentos Antineoplásicos / Antraciclinas / Proteínas Priônicas / Antibióticos Antineoplásicos Idioma: En Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Austrália